Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It seems that CO2 emissions trading operations are alive and well in the USA:
http://www.rggi.org/docs/PR031612_Auction15Results.pdf
I am still long. I don't think anything has changed.
I guess you got answer, lift off was today, LOL!
Nice rally, nice close and volume!!!
That sick feeling I had 3 days ago is gone ,now, LOL!
Long live the TTEG Longs!!!
I am still waiting, and I marked it, LOL!
If Byron could recycle CO2 (at a profit), the way he recycles these PRs, we would all be rich already.
Maybe we can harness all the hot air in the PRs?
LOL
Yep it could have been worse, you could of held back down to .001, LOL!
He is doing very well now.
But do NOT hold your breath!!!
LOL
I gave chillar the office number at the other public company Steve also runs, that is doing well drilling, yesterday. Hope to get some feed back soon.
http://www.contactexp.com/Corporate_Board_of_directors_.html
I guess it is a Zen thing, we just all need to picture EGOH at .01!!!!
LOL
LOL, Pumpin the pumpers, I love it!!!! Go pumpers, oops, I mean go EGOH!!!
Try this:
http://ih.advfn.com/p.php?pid=nmona&article=52161743&symbol=AXPW
Signs of real future life I think, but still too early to call this a real investment I think, as long as the cash burn continues unabated.
CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical company specializing in oncology, today announced the initiation of a Phase 2 clinical trial evaluating the preliminary efficacy and safety of INNO-206 in patients with advanced pancreatic ductual adenocarcinomas (PDA) who have progressed after receiving two prior therapies. PDA is a malignant tumor arising from the duct cells within a gland in the pancreas, and represents about 80% of all pancreatic cancers.
CytRx holds the worldwide rights to INNO-206, which is a tumor-targeted conjugate of the widely used chemotherapeutic agent doxorubicin. INNO-206 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of patients with pancreatic cancer.
Daniel Von Hoff, M.D., Physician-in-Chief and Distinguished Professor at the Translational Genomics Research Institute (TGEN) in Phoenix will serve as the clinical trial’s principal investigator while TGen’s subsidiary, TGen Drug Development, manages this Phase 2 clinical trial on behalf of CytRx. Dr. Von Hoff was a former member of the National Cancer Advisory Board and the FDA’s Oncology Drug Advisory Committee, and former President of the American Association for Cancer Research. He currently co-directs the Pancreatic Cancer Dream Team, one of five Stand Up 2 Cancer teams comprised of renowned scientists working collaboratively on innovation, acceleration, targeted therapy and translational research in several major cancers.
“We are very excited to evaluate the activity and safety of INNO-206 in patients with advanced PDA whose disease has progressed following treatment with both gemcitabine and 5-fluorouracil-containing chemotherapy regimens, which are currently the recognized standard treatments for this cancer,” said Dr. Von Hoff. “INNO-206 binds rapidly and virtually completely to albumin, the most abundant protein in blood. We know that PDAs are albumin starved and appear to preferentially collect and transport this protein. It is our hope that INNO-206 will use the albumin transport mechanism to collect drug at the tumor site, release cytotoxic doxorubicin and destroy the cancer cells, while being less harmful to normal tissues than free doxorubicin.”
The open-label Phase 2 clinical trial will enroll up to 27 patients at multiple clinical sites in the U.S. Trial patients will be treated with intravenously administered INNO-206 once every three weeks for up to eight cycles at a dose of 350 mg/m2 (the maximum tolerated dose established in two Phase 1b clinical trials, including the Phase 1b/2 trial currently being completed at the Sarcoma Oncology Center in Santa Monica, California). Trial patients will be evaluated for objective tumor response (measured by Response Evaluation Criteria in Solid Tumors or RECIST 1.1 criteria), with secondary endpoints including disease control (complete and partial responses, and stable disease at four months), as well as progression-free and overall survival.
In a preclinical trial conducted by INNO-206 inventor Felix Kratz, Ph.D., Department of Medical Oncology, Clinical Research, at the Tumor Biology Center, INNO-206 in combination with either doxorubicin or a novel albumin-binding methotrexate drug induced complete tumor remissions in animal models of human pancreatic cancer. The results were presented at the American Association for Cancer Research (AACR) 2012 Annual Meeting this month.
“We are delighted to initiate a Phase 2 trial with INNO-206 in this solid tumor indication and are highly encouraged by prior animal trial results in pancreatic cancer models, which are extremely difficult to treat. Tumors may grow in the pancreas without any symptoms at first, which means that the disease is often in an advanced stage when it is diagnosed,” said CytRx President and CEO Steven A. Kriegsman. “Pancreatic cancer is the fourth most common cause of cancer-related deaths in the U.S. with more than 43,000 new cases reported in 2010 and 37,000 deaths attributed to this disease each year.”
CytRx also is evaluating INNO-206 in other cancer indications. The Company has completed enrollment and treatment in a Phase 1b/2 clinical trial with INNO-206 in patients with advanced solid tumors (primarily soft tissue sarcomas), and has initiated an international Phase 2b clinical trial in patients with soft tissue sarcomas, comparing the efficacy and safety of INNO-206 to doxorubicin, a standard treatment for soft tissue sarcomas. The Phase 1b/2 clinical trial results will be presented by Sant P. Chawla, M.D., F.R.A.C.P., Director of the Sarcoma Oncology Center in Santa Monica, California, at the American Society of Clinical Oncology (ASCO) meeting in early June 2012. Earlier this month, CytRx announced the issuance of a key patent by the U.S. Patent and Trademark Office covering INNO-206’s linker platform technology and INNO-206 pharmaceutical compositions.
I thought they did a reverse split before they issued the 25 million shares? Doesn't Brent P., AKA Westrock now own about 75% of MNLU, which he still has not admitted or filled the proper SEC disclosure forms for?
http://www.otcmarkets.com/stock/MNLU/company-info
The dogs have not even updated the OS here, still showing the 8 million shares that was once 80 million shares before the R/S. The 25 million new shares are not listed here yet. What is 25 out of 33 million, 75.75%?
Next they will dilute more to raise cash, private placement at a 50-75% discount no doubt.
And Brent P already owned 21% of MNLU before the R/S, unless he dumped the shares and failed to report that to the SEC as well! And MNLU still owes him 1.5 million in cash, and they have about 6-8 million in bad debt and liens. NG is on the floor (or in the pit of hell, LOL), so where do you see any bright spots on this junk already? LOL
Let me know of you need other info, or have other questions, I have a lot of other DD info as well.
NO, they have issued no new shares of MVTG to raise the 3.2 million. They sold subscriptions in BC Canada only, of the Mantra Energy stock, which is a non-listed, non tradeable stock, a subsidiary of MVTG. MVTG owned 9.2 million shares (100%) of Mantra Energy, a non-public subsidiary of MVTG, and once all subscription payments have been made, MVTG will still own 6 million shares of the 9.2 million shares of Mantra Energy, and have 3.2 million in cash in the bank account of Mantra Energy. They only needed about $500,000 to build the LaFarge pilot plant.
Looks like we just covered the gap on that chart. I am waiting for the next real bottom to do some serious buying to add to what I have. This could be a long a wait here.
I don't think IHUB policy allows SE to post his current thoughts about BW on this board, LOL, due to the nature of the language it would include!
So will I! LOL
Ask Wilmont!!!! Then ask him why he did not take the offer!!!
I think he is willing to sell, he is just delusional as to its market value, and thus will drag investors to zero value as he dilutes to try and bail out a sinking ship. Either way, scam, or fool, he is taking it down into DEEP water, like the Titanic.
No sane person would have turned down the last offer he had, even if he was a scammer.
I think the dump started earlier, but yes it went into high gear today! When the MM's are finished dumping the new shares, support will disappear, then .0001, and a R/S.
Same here. Wilmont blew his last chance last week I think. He got greedy and asked for too much and the last offer he had on the table walked away. That is why the Nevada A/S was raised, and the printing machine is in high gear now, because no one is left that is willing to try and work with him.
He refuses to accept extremely reasonable and generous offers. He is delusional as to what he thinks he can sell or JV a deal for. He was offered a deal that would have turned this into a $1 stock overnight, and he turned it down by asking for more, and the offer was pulled!!! He turned down more than one offer! At this point, no one will offer more, or bother wasting time making an offer, as he has already turned down a blue sky offer already that no one else will try and beat!!! There are too many other easier, cheaper to deal sites to JV!!!!!
He and EGOH are done for now. All the longs, including me are basically screwed now, unless the MOMO MM's run this way up this week to dump more shares later.
I, like many others, thought Wilmont would see reality and sell, or give up control to a real operator in a JV, but no, he refuses, and he has a bad history of driving prior public companies he ran and controlled into the ground.
Just Google Buzzard Bait Company and Wilmont for one!!!! LOL!
Ford Spoleti Holdings, Eagle Environmental, and about 6 others we know of, including a public bank, he ran into the ground! Once again History, repeats itself.
Not to self: Never bet on a 6 time looser, zero wins, horse.
Interesting, Stockcharts is showing 45 million shares traded on your chart post, while Fidelity only shows 35 million traded today.
Brian A.
http://www.legalmetric.com/cases/securities/vawd/vawd_400cv00067.html
Or Brian D
I think it must be Brian D:
https://www.google.com/search?q=brian+wilmont+buzzard+bait&ie=utf-8&oe=utf-8&aq=t&rls=org.mozilla:en-US:official&client=firefox-a#hl=en&gs_nf=1&gs_mss=%22brian%20d.%20wilmot%22%20eagle%20oil&tok=cBJ8icEJKQzjoPFIbIZpDQ&pq=%22brian%20a.%20wilmot%22%20buzzard%20bait&cp=8&gs_id=1uqw&xhr=t&q=%22brian+d+wilmot%22+eagle+oil&pf=p&client=firefox-a&hs=VvV&rls=org.mozilla:en-US%3Aofficial&sclient=psy-ab&oq=%22brian+d+wilmot%22+eagle+oil&aq=f&aqi=&aql=&gs_l=&pbx=1&bav=on.2,or.r_gc.r_pw.r_qf.,cf.osb&fp=1cf78a1087d701eb&bs=1
http://www.zoominfo.com/#!search/profile/person?personId=9441952&targetid=profile
http://people.forbes.com/profile/brian-d-wilmot/129563
JACK POT!!!!! Take a look at this!!!!
http://www.zoominfo.com/CachedPage/?archive_id=0&page_id=13492558&page_url=//www.egvr.com/news.htm&page_last_updated=2012-02-09T08:20:20&firstName=Brian&lastName=Wilmot
Do the math. Cayman Island loan 6 months ago, was $30,000 backed by sellable shares at 50% of market IIRC, so 60 million new shares issued and dumped to convert the debt. I think he had other, older convertible debt, that may be getting converted again too?
New Daytraders got sucked in here by the pump today, made bids at the lower bid, and got the shares dumped on them by the hedge fund MMs from the looks of it.
I don't think Wilmont is selling his shares, in fact he may have issued himself shares to keep controlling interest so he can not be voted out of office.
R/S is probably coming this year now.
Sad to stay that the SEC has no jurisdiction over CEO stupidity, incompetence or insanity that I know of.
Problem seems to be split personality disorder, perhaps Schizophrenia with Wilmont. From what all I have heard and read, he makes a deal, then breaks it, or tries to change it, leading to deals falling apart in the middle of closing a deal, after a deal has been made, etc. Dealing with him, trying to do business with him, is reportedly harder than catching a greased pig.
I doubt anyone could prove fraud, incompetence YES!
I am hoping the guy slips on a banana peel real soon, and the kids take over. Surely they can be no worse than Wilmont, unless insanity runs in the family genes!!!
WCD, I thought it was a DUMP and PUMP? JK.
BTW, SE wants to know how to get BLOOD out of a rock? (Think Wilmont!!!)
I told him to use a BFH!!!!!
LOL!
I too think EGOH is now well done, cooked fried and boiled by Wilmont, very sad, what a waste.
I am amazed the price did not crash already.
I now think we would get more out of our shares if we just use them for TT, or winter fuel to burn. Next question is has the dumping just started, or ended, for now.
Thanks for the update, all sounds like great news!!
Quarterly report is filed:
http://ih.advfn.com/p.php?pid=nmona&article=52113417
As SE loves to say, I made her wink today! LOL
The seller(s) disappeared today, so I took the opportunity to make her wink!!!
BTW, in case I did not tell you already, we are expecting a patent allowance decision overseas this summer (China or India I think), and also expecting news to start flowing this summer on actual ground breaking construction of the LaFarge Pilot plant for the first mini-commercial ERC plant, now that the cash to build the pilot plant has been secured.
Thanks for trying to reach him. Soon or later they will do something. The quarterly is past due, and they a filed a late notice filing, so they are still operating.
LOL, I thought he sold the shoes too!!! So how can he tie them?
I am not selling this cheap, and I sure as hell am not selling here, if I did not sell at .17 or .20 or .27 the last year or so!!! And I did not sell, LOL, I am still a bag holder, LOL, and just a bit frustrated at the size of the sell off.
And if it gets dirt cheap again I will average down and buy more, like I did late last year. I just hate loosing money on paper like this.
LOL, a great Positive attitude indeed!!!
I don't think he is selling these shares. I think the Cayman Island shares have arrived, debt conversion. I also fear Wilmont (EGOH CEO) raised the OS so he could issue himself more shares to keep controlling interest of the company shares, while he borrows more cash from the Cayman line of credit with new shares. SO, the "Scumbag" part is right! LOL
I think it is time we all told Wilmont to take the best offer on the table, and step aside, or else we will all turn the SEC Fraud division loose on him. That threat might just get his attention!!!
Are you reading this Wilmont????
He would probably screw that up too, LOL.
No idea, but wishing I had sold at the last 2 highs right now.
I am considering running a special on EGOH Wilmont Dart Boards today!!!